Pineta Grande Hospital Leads in Atrial Fibrillation Management with Innovative Non-Thermal Ablation

The "Pineta Grande Hospital" in Castelvolturno continues to be at the forefront in managing patients with atrial fibrillation, a condition that affects millions of people each year. The private facility in Caserta is among the first in Italy where ablation is treated with the "PFA Medtronic PulseSelectTM" system, a new method that uses a non-thermal approach supported by over 15 years of clinical and preclinical research and now available on the market. The procedure, adopted by doctors Stefano Nardi and Luigi Argenziano with their highly specialized team, allows for the treatment of all forms of atrial fibrillations (paroxysmal and persistent) in complete safety, reducing procedural complications well below 1%. "Transcatheter ablation has revolutionized the treatment of patients suffering from atrial fibrillation, the most common cardiac rhythm disorder," explains Stefano Nardi, head of the Arrhythmology and Cardiac Electrophysiology center at Pineta Grande Hospital. "A condition due to the fluttering (or fibrillation) of the two upper chambers (atria) of the heart, affecting about 33 million people worldwide, 4.5 million in the European Union, and causing patients to feel fatigued and unwell, increasing mortality and, up to five times, the risk of stroke." "Today, the available treatments are able to reduce symptoms and complications," continues Luigi Argenziano, head of the Cardiac Intensive Care Unit at Pineta Grande Hospital. "For years we have effectively treated patients with traditional thermal ablation systems, particularly with cryoablation, and today we are proud to be able to offer our patients the most advanced technological solutions and the most efficient therapeutic options."